Actinium Clinical Advisory Board Chair to Participate in the 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics Nov 11, 2014
Actinium Pharmaceuticals Actimab-A Phase I/II Trial Interim Data Demonstrate Extension of Overall Survival to 9.1 Months in Elderly Secondary Acute Myeloid Leukemia Nov 6, 2014
Actinium Announces Collaboration With Albert Einstein College of Medicine on New Actinium Program Oct 27, 2014
Final Reminder Related to Actinium's Key Opinion Leader Event Focused on Emerging Therapies for Acute Myeloid Leukemia on October 21st in New York City Oct 20, 2014
Actinium to Host Key Opinion Leader Event Focused on Emerging Therapies for Acute Myeloid Leukemia on October 21 in New York City Oct 14, 2014
Actinium to Present at the 14th Annual Biotech in Europe Forum for Global Partnering and Investment on September 30th Sep 25, 2014
Actinium Advisory Board Chairman to Participate in the Cancer Advance Boston: Focus on Innovation Conference at Harvard Medical School Sep 23, 2014
Actinium to Present at the 21st Annual BioCentury NewsMakers Conference on Friday, September 26th Sep 16, 2014
MD Anderson Department Chair Richard E. Champlin, M.D. Joins Actinium’s Iomab™-B Scientific Advisory Board Sep 10, 2014
